申请人:ILDONG PHARMACEUTICAL CO., LTD. 일동제약(주)(120160670930) Corp. No ▼ 110111-6139277BRN ▼803-88-00431
公开号:KR20210076693A
公开(公告)日:2021-06-24
본 출원은 질소를 포함하는 헤테로고리로 치환된 축합 피리미딘 유도체 및 그의 의약 용도에 관한 것으로서, 하기의 화학식 I로 표시되는 화합물, 용매화물, 입체 이성질체 또는 이들의 약학적으로 허용가능한 염, 및 이를 포함하는 암의 예방 또는 치료용 약제학적 조성물을 제공한다: [화학식 I] .
The present invention provides compounds of Formula (I): wherein A, Y and R1 are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists
作者:Phillip M. Cowley、James Baker、David R. Barn、Kirsteen I. Buchanan、Ian Carlyle、John K. Clark、Thomas R. Clarkson、Maureen Deehan、Darren Edwards、Richard R. Goodwin、David Jaap、Yasuko Kiyoi、Chris Mort、Ronald Palin、Alan Prosser、Glenn Walker、Nick Ward、Grant Wishart、Trevor Young
DOI:10.1016/j.bmcl.2010.10.104
日期:2011.1
The discovery and structure-activity relationship of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB1 receptor is disclosed. Compound 26i was found to be a high potency, selective cannabinoid CB1 antagonist. (C) 2010 Elsevier Ltd. All rights reserved.
TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20180244671A1
公开(公告)日:2018-08-30
The present invention provides compounds of Formula (I): wherein A, Y and R
1
are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
Charge-controlled Pd catalysis enables the meta-C–H activation and olefination of arenes
作者:Arup Mondal、Marina Díaz-Ruiz、Fritz Deufel、Feliu Maseras、Manuel van Gemmeren
DOI:10.1016/j.chempr.2022.12.019
日期:2023.1
meta-selective activation and olefination of arenes to address these challenges in Pd catalysis. The charged moiety can easily be converted to uncharged simple arenes by hydrogenation or cross-coupling. In-depth mechanisticstudies prove that the charge is responsible for the observed selectivity. We expect our studies to be generalizable and thereby enable further regioselective transformations.